Yasser Iturria-Medina

Yasser Iturria-Medina

Auto-generated profile, based on publicly available information

Yasser Iturria-Medina

Montreal Neurological Institute, McGill University, Montréal, Canada

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2016 in Nature Communications
Verified
Journal Article
Open access
YIY. Iturria-Medina
Y. Iturria-Medina
RSR. C. Sotero
R. C. Sotero
PTP. J. Toussaint
P. J. Toussaint
JMJ. M. Mateos-Pérez
J. M. Mateos-Pérez
AEA. C. Evans
A. C. Evans
TIThe Alzheimer’s Disease Neuroimaging Initiative
The Alzheimer’s Disease Neuroimaging Initiative
Multifactorial mechanisms underlying late-onset Alzheimer’s disease (LOAD) are poorly characterized from an integrative perspective. Here spatiotemporal alterations in brain amyloid-β deposition, metabolism, vascular, functional activity at rest, structural properties, cognitive integrity and peripheral proteins levels are characterized in relation to LOAD progression. We analyse over 7,700 brain images and tens of plasma and cerebrospinal fluid biomarkers from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Through a multifactorial data-driven analysis, we obtain dynamic LOAD–abnormality indices for all biomarkers, and a tentative temporal ordering of disease progression. Imaging results suggest that intra-brain vascular dysregulation is an early pathological event during disease development. Cognitive decline is noticeable from initial LOAD stages, suggesting early memory deficit associated with the primary disease factors. High abnormality levels are also observed for specific proteins associated with the vascular system’s integrity. Although still subjected to the sensitivity of the algorithms and biomarkers employed, our results might contribute to the development of preventive therapeutic interventions.

29 April 2021 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
TIThe Alzheimer’s Disease Neuroimaging Initiative
The Alzheimer’s Disease Neuroimaging Initiative
JVJacob W. Vogel
Jacob W. Vogel
AYAlexandra L. Young
Alexandra L. Young
NONeil Oxtoby
Neil Oxtoby
RSRuben Smith
Ruben Smith
OHOskar Hansson
Oskar Hansson

1 April 2008 in NeuroImage
Verified
Journal Article
Closed access
YIYasser Iturria-Medina
Yasser Iturria-Medina
RSRoberto C. Sotero
Roberto C. Sotero
Erick Jorge Canales-RodríguezErick Jorge Canales-Rodríguez
Erick Jorge Canales-Rodríguez
YAYasser Alemán-Gómez
Yasser Alemán-Gómez
LGLester Melie Garcia
Lester Melie Garcia

26 May 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
JVJacob W. Vogel
Jacob W. Vogel
YIYasser Iturria-Medina
Yasser Iturria-Medina
OSOlof T. Strandberg
Olof T. Strandberg
RSRuben Smith
Ruben Smith
ELElizabeth Levitis
Elizabeth Levitis
OHOskar Hansson
Oskar Hansson
Tau is a hallmark pathology of Alzheimer’s disease, and animal models have suggested that tau spreads from cell to cell through neuronal connections, facilitated by β-amyloid (Aβ). We test this hypothesis in humans using an epidemic spreading model (ESM) to simulate tau spread, and compare these simulations to observed patterns measured using tau-PET in 312 individuals along Alzheimer’s disease continuum. Up to 70% of the variance in the overall spatial pattern of tau can be explained by our model. Surprisingly, the ESM predicts the spatial patterns of tau irrespective of whether brain Aβ is present, but regions with greater Aβ burden show greater tau than predicted by connectivity patterns, suggesting a role of Aβ in accelerating tau spread. Altogether, our results provide evidence in humans that tau spreads through neuronal communication pathways even in normal aging, and that this process is accelerated by the presence of brain Aβ.

1 July 2007 in NeuroImage
Verified
Journal Article
Closed access
YIY. Iturria-Medina
Y. Iturria-Medina
Erick Jorge Canales-RodríguezErick Jorge Canales-Rodríguez
Erick Jorge Canales-Rodríguez
LGLester Melie Garcia
Lester Melie Garcia
PVP.A. Valdés-Hernández
P.A. Valdés-Hernández
EME. Martínez-Montes
E. Martínez-Montes
JBJose Miguel Sanchez Bornot
Jose Miguel Sanchez Bornot

1 July 2019 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
VHVladimir Hachinski
Vladimir Hachinski
KEKarl Einhäupl
Karl Einhäupl
DGDetlev Ganten
Detlev Ganten
SASuvarna Alladi
Suvarna Alladi
CBCarol Brayne
Carol Brayne
ZKZaven S. Khachaturian
Zaven S. Khachaturian